Apotex Biotechnology Holdings Inc., Cangene deal

CNJ continued a corporate restructuring, announcing an agreement in principle under which Apotex (ABH) would become a majority owner of the company, and a plan to return to CNJ shareholders substantially

Read the full 313 word article

How to gain access

Continue reading with a
two-week free trial.